LivaNova (LIVN) Share-based Compensation (2015 - 2026)
LivaNova (LIVN) posted Share-based Compensation of $8.3 million for Q1 2026, up 927.33% sequentially from $805000.0 in Q4 2025, and up 6.26% YoY from $7.8 million in Q1 2025.
LivaNova (LIVN) Share-based Compensation (2015 - 2026) Analysis & Trends
LivaNova has reported Share-based Compensation for 12 years, with the latest figure at $8.3 million in Q1 2026.
- Quarterly Share-based Compensation rose 6.26% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 84.39% YoY) and the FY2025 annual result came in at $4.4 million, down 86.94% from the prior year.
- Share-based Compensation improved to $8.3 million in Q1 2026 per LIVN's latest filing, from $805000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $29.4 million in Q4 2023 and troughed at -$3.9 million in Q2 2025.
- A 5-year average of $7.5 million and a median of $8.2 million in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation surged 641.68% in 2024, then plunged 147.59% in 2025.
- Over 5 years, Share-based Compensation stood at $12.3 million in 2022, then soared by 138.35% to $29.4 million in 2023, then slumped by 76.33% to $6.9 million in 2024, then slumped by 88.42% to $805000.0 in 2025, then jumped by 927.33% to $8.3 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $8.3 million, $805000.0, and -$256000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 12.80 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 16.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.88 Mn |
| Jun 30, 2026 | 16.88 Mn |
| Mar 31, 2026 | 8.27 Mn |
| Mar 31, 2026 | 8.27 Mn |
| Dec 31, 2025 | 805,000.00 |
| Dec 31, 2025 | 805,000.00 |
| Sep 30, 2025 | -256,000.00 |
| Sep 30, 2025 | -256,000.00 |
| Jun 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 8.56 Mn |
| Sep 30, 2024 | 8.56 Mn |
| Jun 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 8.20 Mn |
| Mar 31, 2024 | 10.23 Mn |
| Mar 31, 2024 | 10.23 Mn |